 |
|
| LEUKEMIA RESEARCH
| |
| | |
|
|
 Clinical and Laboratory Studies
Editors-in-Chief:
John M. Bennett, Terry J. Hamblin
See editorial board for all editors information
Description
Leukemia Research is an international journal which brings comprehensive and current information to
all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other
hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry,
cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.
Specifically, of major interest will
be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics
and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected
articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients
with a wide range of neoplasms.
For more information contact the Myelodysplastic Syndromes Foundation at  http://www.mds-foundation.org/
Bibliographic & ordering information
ISSN: 0145-2126
Imprint: ELSEVIER
Commenced publication 1977
Subscriptions for the year 2008,
Volume 32,
12 issues
Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.
Institutional price: Order form
USD 2,958 for all countries except Europe, Japan and Iran
EUR 2,645 for European countries and Iran
JPY 351,100 for Japan
Personal price: Order form
EUR 336 for European countries and Iran
JPY 44,400 for Japan
USD 375 for all countries except Europe, Japan and Iran
Personal price UK: Order form
GBP 234
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Medical scientists, haematologists, immunologists, oncologists and chemotherapists.
Impact factor of this journal
2006: 2.483
Journal Citation Reports® 2007, published by Thomson Scientific
063/631
Last update: 19 May 2008
|
|
| |
| | |
|
|
| |
